← Back to Search

Patient Engagement Tool for Overactive Bladder

N/A

Waitlist Available

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Female aged 18 years or older

OAB symptoms for at least 3 months

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

Study Summary

This trial is researching how to better diagnose and treat OAB/UI, which affect 33 million Americans. The goal is to improve patient symptoms & QOL and reduce undertreatment, especially in vulnerable populations.

Who is the study for?

This trial is for women over 18 with overactive bladder (OAB) symptoms for at least 3 months, who can understand English or Spanish. They should not have had certain treatments in the past year and must be new to behavioral treatment. Excluded are those with specific medical conditions like severe bladder issues, neurological diseases, or a history of pelvic radiation.Check my eligibility

What is being tested?

The study tests a patient engagement tool designed to improve access and adherence to OAB treatments. It aims to address underdiagnosis and undertreatment by providing tailored education on disease management, expected outcomes, costs, and side effects.See study design

What are the potential side effects?

Since this trial focuses on a patient engagement tool rather than medication or invasive procedures, traditional side effects are not applicable. However, there may be indirect consequences related to changes in how patients manage their OAB treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a woman aged 18 or older.

Select...

I have had overactive bladder symptoms for at least 3 months.

Select...

I have OAB and haven't had specific therapy or medication for it in the last year.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

OAB knowledge

Usability and Engagement

Secondary outcome measures

Change in symptom severity

OAB management satisfaction

Patient Global Impression of Improvement (PGI-I)

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Patient Engagement Tool (PET)Experimental Treatment1 Intervention

Participants will use the PET weekly for 12 weeks

Group II: Usual CareActive Control1 Intervention

Usual Clinic Follow up every 6 weeks for 12 weeks

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,360 Previous Clinical Trials

4,314,822 Total Patients Enrolled

Stanford UniversityLead Sponsor

2,395 Previous Clinical Trials

17,341,425 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any more participants being welcomed into this medical experiment?

"According to information on clinicaltrials.gov this study has ceased recruitment, having first been posted in December 1st 2023 and updated most recently October 16th 2023. Nevertheless, there are 207 other trials actively searching for participants at the moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Improving Overactive Bladder Treatment Access and Adherence

Ekene Enemchukwu 2023. "Improving Overactive Bladder Treatment Access and Adherence". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06094543.

All > Overactive Bladder